导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.40% | 4406/4981 |
| 近一周 | -2.83% | 4752/5421 |
| 近一月 | -1.57% | 661/5424 |
| 近一季 | 0.82% | 971/5380 |
| 近半年 | -13.28% | 4287/5140 |
| 近一年 | -24.31% | 4414/4741 |
| 近两年 | -0.69% | 4076/4207 |
| 近三年 | -24.51% | 3533/3662 |
| 成立以来 | 97.28% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.85% 4207/5130 |
-11.42% 4574/5464 |
- - |
- - |
| 2025 | -1.69% 4367/5130 |
0.31% 3574/4624 |
-1.35% 3692/4802 |
6.42% 4322/4970 |
-6.65% 3895/5130 |
| 2024 | -2.10% 2918/4618 |
-1.99% 1912/4340 |
-10.34% 4013/4442 |
17.80% 497/4550 |
-5.42% 3297/4618 |
| 2023 | -12.85% 1481/4216 |
6.01% 802/3759 |
-5.26% 2280/3909 |
-7.60% 1962/4055 |
-6.09% 2569/4209 |
| 2022 | -17.93% 902/3578 |
-18.76% 1650/2804 |
10.93% 826/3205 |
-18.03% 2851/3430 |
11.09% 159/3570 |
| 2021 | -5.67% 1255/2717 |
-0.08% 396/1745 |
6.01% 1305/2232 |
-15.00% 2095/2560 |
4.77% 694/2708 |
| 2020 | 104.08% 19/1596 |
-5.47% 749/1036 |
33.28% 167/1256 |
22.88% 57/1472 |
31.83% 24/1690 |
| 2019 | 54.74% 177/926 |
29.16% 497/3053 |
-0.67% 1639/3201 |
2.69% 660/939 |
17.45% 49/1014 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0224 | 56.52% |
| 招商创新增长混合A | 1.0959 | 55.91% |
| 招商创新增长混合C | 1.0424 | 55.61% |
| 招商品质成长混合A | 1.0640 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6963 | 50.99% |
| 华泰柏瑞医疗健康C | 2.6332 | 50.85% |
| 大摩优悦安和混合A | 0.9071 | 48.05% |
| 大摩优悦安和混合C | 0.8904 | 47.91% |
| 中信建投医药健康A | 0.8091 | 39.62% |
| 中信建投医药健康C | 0.7713 | 39.35% |
| 华夏新兴消费混合A VS. 长安宏观策略混合A(740001) |